Outcomes of Patients Over 75 Years of Age Who Consulted the Emergency Department for a Medical Problem (GERIA-UH)

December 10, 2025 updated by: University Hospital, Strasbourg, France

Outcomes of Patients Over 75 Years of Age Who Consulted the Emergency Department for a Medical Problem, Depending on Their Direct Admission to a Medical Ward Versus Prior Hospitalization in the Short-Stay Unit (UHCD).

The increasing activity of emergency departments, coupled with a decrease in the number of hospital beds, is leading to operational changes, of which the Short-Stay Unit (UHCD) is one example. Initially designed for stays of less than 24 hours, it now finds itself providing supplementary hospitalization for downstream services, which is detrimental to the most vulnerable elderly patients.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Strasbourg, France, 67091
        • Recruiting
        • Service de Soins de Soins Médicaux et de Réadaptation - Réanimation - CHU de Strasbourg - France
        • Contact:
        • Principal Investigator:
          • Alexandre BOUSSUGE, MD
        • Principal Investigator:
          • Margaux HANNE, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Patient aged ≥ 75 years admitted to the Strasbourg Emergency Department (Hautepierre and NHC) during 2019 for an acute medical problem

Description

Inclusion Criteria:

  • Patient aged ≥ 75 years
  • Patient admitted to the Strasbourg Emergency Department (Hautepierre and NHC) during 2019 for an acute medical problem
  • Patient with an indication for hospitalization in a conventional medical ward

Exclusion Criteria:

  • Patient who died during their visit to the Emergency Department prior to hospitalization
  • Patient admitted for a scheduled hospitalization
  • Patient not requiring hospitalization in a conventional medical ward (either discharged home after the Emergency Department visit or admitted to intensive care)
  • Patient admitted to the Emergency Department for a surgical condition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
3-month mortality rate depending on whether or not they were hospitalized in the UHCD.
Time Frame: 3-month mortality rate after hospitalization
3-month mortality rate after hospitalization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Strasbourg, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 13, 2025

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Study Registration Dates

First Submitted

December 10, 2025

First Submitted That Met QC Criteria

December 10, 2025

First Posted (Actual)

December 24, 2025

Study Record Updates

Last Update Posted (Actual)

December 24, 2025

Last Update Submitted That Met QC Criteria

December 10, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 9452

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Medical Problem

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe